Originally published In Press as doi:10.1074/jbc.M005957200 on September 6, 2000
J. Biol. Chem., Vol. 275, Issue 49, 38302-38310, December 8, 2000
Redox Switch of Hsp33 Has a Novel Zinc-binding Motif*
Ursula
Jakob
§,
Markus
Eser
¶, and
James C. A.
Bardwell
From the
Department of Biology, University of
Michigan, Ann Arbor, Michigan 48109-1048
Received for publication, July 6, 2000, and in revised form, August 29, 2000
 |
ABSTRACT |
The chaperone activity of the heat shock protein
Hsp33 is regulated by reversible disulfide bond formation. Oxidized
Hsp33 is active, and reduced Hsp33 is inactive. We show that zinc
binding is essential for the function of this redox switch. Our results reveal that Hps33 contains a new, high affinity (Ka > 1017 M
1),
zinc-binding motif in the form
Cys-X-Cys-X27-32-Cys-X-X-Cys. All four conserved cysteines within this motif act to coordinate a
single zinc atom. Experiments where reduced wild type Hsp33 is
reconstituted with cobalt or cadmium demonstrate that the
metal-coordinating cysteines are present as highly reactive thiolate
anions. This ionization may allow for the fast and successful
activation of the chaperone function of Hsp33 upon incubation in
oxidizing agents.
 |
INTRODUCTION |
Hsp33 is a novel heat shock protein present in a wide variety of
prokaryotic species. To date over 30 different Hsp33 homologues have
been identified, all of which share a conserved cysteine motif located
near the C terminus of the protein. These cysteines, which are arranged
in a CXCX27-32CXXC motif,
play an important role in the functional regulation of Hsp33 (1-3).
Under oxidizing conditions, Hsp33 functions as a potent molecular
chaperone, capable of recognizing and binding aggregation-sensitive
folding intermediates (1). This leads to the efficient suppression of
protein aggregation, a common and irreversible side reaction of protein
folding and thermal unfolding events (4). Under reducing conditions,
however, Hsp33 is inactive. The molecular switch of this
activation/inactivation process is mediated by the cysteine-containing
motif of Hsp33 (1). Under reducing conditions, all 4 conserved
cysteines are present as thiol groups. They are titratable with
Ellman's thiol reagent and accessible to thiol modifications such as
alkylation by iodoacetamide (5). Under oxidizing and activating
conditions, these cysteines form two intramolecular disulfide bonds
connecting the next two neighbor cysteines
Cys232-Cys234 and
Cys265-Cys268 (5). The activation process of
Hsp33 appears to be accompanied by major conformational changes in the
protein. Active and inactive Hsp33 preparations show substantially
different mobility on native gels (1). Cys239, a
non-reactive, non-conserved cysteine localized in the vicinity of the
zinc-binding motif of Hsp33 has been shown to become completely buried
upon oxidation and activation. This is additional evidence of a major
conformational change accompanying the disulfide bond formation in
Hsp33 (5). Other molecular chaperones like DnaK and GroEL show
significant conformational changes upon cofactor or co-chaperone
binding that appear to constitute a major regulative part of their
chaperone function (6, 7).
Reduced Hsp33 coordinates zinc via its cysteines (1). Upon activation
of Hsp33, the disulfide bonds form, and zinc is released. Zinc-coordinating cysteine centers, such as present in Hsp33 or zinc
finger proteins, are prime targets for reversible oxidative modification processes and constitute a novel regulatory element of
proteins. Zinc finger transcription factors such as members of the Sp1
family have been demonstrated to be redox-regulated both in
vitro and in vivo (8). The zinc finger of replication protein A as well as the zinc ring finger protein SAG have been shown
to be highly sensitive toward oxidation and reduction processes (9,
10). Metallothionein, an important cytosolic zinc storage protein, has
been shown to utilize disulfide bond formation for its directed zinc
donation (11, 12). This allows the efficient transfer of zinc from the
high affinity zinc centers of metallothionein (Ka = 3.2 × 1013 M
1,
pH 7.4) to proteins with significantly lower zinc affinity (11, 12).
Reversible disulfide bond formation is a very fast and elegant way to
translate changes in environmental conditions into changes in protein
activity. Given that a large number of signal-transducing proteins
contain zinc finger domains, it is of interest to analyze what
properties determine the redox sensitivity of zinc centers.
Although it has been shown that reduced Hsp33 binds zinc, the precise
role of the zinc binding, particularly the question whether zinc plays
a primary structural role or is involved in the activation process, is
not yet known. Neither the stoichiometry of zinc binding nor the
identity of the cysteines involved in the zinc coordination in Hsp33
has been investigated so far. Here we show that Hsp33 has a high
affinity zinc-binding motif consisting of the 4 highly conserved
cysteines. Reconstitution experiments with cobalt and cadmium were
performed to evaluate the composition and geometry of the zinc binding.
Reactivation of Hsp33 in the presence and absence of zinc revealed that
zinc coordination plays an important role in the efficient reactivation
of Hsp33.
 |
MATERIALS AND METHODS |
Cysteine Mutants of Hsp33--
The cysteine mutants in
hsp33 were constructed using the site-specific mutagenesis
system GeneEditorTM (Promega). Wild type hsp33
cloned into the expression vector pET11a (pUJ30) was used as template
for all single or double cysteine mutants (1). The primers were used
individually or in combinations to introduce the respective single or
double mutation. We designated our mutants as follows: D indicates the
cysteine to aspartic acid substitution and S indicates the cysteine to
serine substitutions. Thus C141D has cysteine substituted for aspartic
acid at position 141. The following primers were used: for C141D, 5'
GAT ACC CTG GCG GCC GAT CTA GAA GAT TAC TTT ATG CGT TC 3'; for C239S,
5' ACC TGC TCG CGT GAA CGT TCC GCG GAT GCG CTG AAA ACG CTG 3'; for
C232S, 5' CGC AGG ATG TGG AGT TCA AGT CGA CCT GCT CGC GTG AAC G3'; for C234S, 5' GTG GAG TTC AAA TGC ACT AGT TCG CGT GAA CGT TGC GCC G 3'; for
C265S, 5' GGC GAA ATT GAC ATG CAT TCT GAT TAC TGC GGT AAC CAC 3'; and
for C268S, 5' GAC ATG CAT TGT GAT TAC TCC GGA AAC CAC TAT CTG TTC AAT
GCG 3'.
All introduced mutations were confirmed by sequencing. BL21 strains
were transformed with the respective expression plasmids. The Hsp33
overexpressing strains were grown in LB medium, supplemented with 1 mM ZnCl2, and Hsp33 expression was induced by
the addition of 1 mM
isopropyl-
-D-thiogalactopyranoside. Purification of the Hsp33 mutant proteins was performed in the absence of reducing agents,
according to the purification protocol of wild type Hsp33 (1).
Preparations of Zinc-reconstituted and Metal-free Hsp33--
1.5
ml of purified Hsp33 (100 µM, in 40 mM
HEPES-KOH, pH 7.5) was incubated in 2 mM
DTT1 and 20-100
µM ZnCl2 for 30 min at 37 °C. To prepare
metal-free Hsp33, 1.5 ml of purified Hsp33 (50 µM, in 40 mM HEPES-KOH, pH 7.5) was incubated in 2 mM DTT
and 2 mM
N,N,N',N'-tetrakis(2-pyridyl-methyl)ethylenediamine (TPEN)
for 4 h at 43 °C. Zinc-reconstituted and metal-free samples were supplemented with 1 ml of 40 mM HEPES-KOH, pH 7.5, and
applied onto a PD10 column (Amersham Pharmacia Biotech). The PD10
columns were either equilibrated in metal-free 40 mM
HEPES-KOH buffer (5 g of Chelex and 100 ml of 40 mM
HEPES-KOH, pH 7.5, incubated for 1 h at 37 °C) for zinc
measurements or in untreated 40 mM HEPES-KOH for activity
measurements. The protein was eluted with 2.5 ml of metal-free or
untreated 40 mM HEPES-KOH buffer, respectively, and the
protein concentration was determined using an extinction coefficient of
0.545 mg
1 cm
1 (1).
When metal determinations were performed, only new plastic ware was used.
Determination of Accessible Thiol Groups in Wild Type Hsp33 and
the Mutants--
Accessible thiol groups in wild type Hsp33 and the
mutant proteins were determined in 6 M Gdn·HCl according
to Creighton (13).
PAR-PMPS Assay--
Zinc determination and analysis of the
number of zinc-coordinating cysteines were performed according to Hunt
et al. (14). The assay is based on the complex formation of
free zinc with the zinc-complexing dye 4-(2-pyridylazo) resorcinol
(PAR), which produces an intense red dye (
500 = 66 000 M
1
cm
1). To analyze the amount of free or
surface-bound zinc in wild type Hsp33, untreated or zinc-reconstituted
Hsp33 was incubated with 100 µM PAR in 40 mM
metal-free HEPES-KOH, pH 7.5, and the A500 was monitored using a Beckman DU600
spectrophotometer. To determine the number of cysteines involved in the
zinc coordination, defined volumes of 0.2-0.5 mM
p-hydroxymercuriphenylsulfonic acid (PMPS) titration
solution (in 100 µM PAR, metal-free 40 mM
HEPES-KOH, pH 7.5) were added, and the changes in
A500 were recorded. PMPS forms mercaptide bonds
with thiols, leading to the release of zinc into the solution where it
is immediately complexed by PAR, thereby turning the solution red (14).
The PMPS titration solution was added until all zinc was released from
the proteins, as indicated by a constant A500
signal. To initiate the reassociation of zinc to apoHsp33, 40 µM DTT was added to the incubation reaction to displace
PMPS from the cysteines. The change in A500 over
time was monitored. To exclude the possibility that DTT re-extracts zinc from PAR rather then reducing the thiol-mercaptide bonds in Hsp33,
a control experiment was performed in which 40 µM DTT were added to a 20 µM zinc solution in 100 µM PAR, 40 mM HEPES-KOH, pH 7.5. No
significant decrease in A500 could be monitored
after the addition of DTT, indicating that DTT, at this low
concentration used, was unable to re-extract zinc from the
Zn(PAR)2 complex.
To determine the number of thiols in Hsp33, thiol titrations with PMPS
in the absence of PAR were performed. Mercaptide thiol bonds show a
strong absorption at A250. To titrate the thiol
groups in wild type Hsp33 and the mutants, defined volumes of 0.2 mM PMPS (in 40 mM HEPES-KOH, pH 7.5) titration
solution were added to Hsp33 (3 µM in the same buffer),
and the changes in A250 were monitored until
further addition of PMPS failed to change the absorption. This
indicated that all of the thiols have been titrated. Changes in protein
and PMPS concentration due to the volume changes during the titrations
were calculated accordingly.
Determination of Zinc Binding Constant--
Hsp33 wild type and
mutant proteins were reconstituted with zinc as described, and DTT and
unbound zinc were removed using PD10 gel filtration columns that had
been equilibrated in metal-free 40 mM HEPES-KOH, pH 7.5, buffer. To determine the equilibrium between Hsp33 and zinc,
competition experiments between Hsp33 and the metal-complexing agent
TPEN (Ka = 1016
M
1) were performed. Zinc
coordinating wild type Hsp33 (40 µM) was incubated in
metal-free 40 mM HEPES, pH 7.5, 0.2 mM DTT and
increasing concentrations of TPEN (20 µM to 5 mM) for 16 h at 23 °C. The effective TPEN
concentration present at pH 7.5 was calculated according to the
pKa of 7.19 of TPEN (15). After equilibrium was
reached, 100-µl aliquots were taken, supplemented with metal-free 40 mM HEPES-KOH applied to a PD10 column, and equilibrated in the same buffer. The protein was eluted with 2 ml of metal-free 40 mM HEPES-KOH, and the protein concentration was determined. 540 µl of the eluate was tested with the PAR/PMPS assay for the remaining amount of zinc bound to the cysteine center of Hsp33. To
exclude the presence of residual TPEN in the sample, which would
immediately bind to the zinc released from the cysteine centers of
Hsp33 upon PMPS addition, a defined amount of zinc was added after the
PMPS addition. The absorption corresponded well with the amount of zinc
added and excluded the presence of even submicromolar concentrations of
TPEN present in the gel-filtered sample. Based on the binding constant
of TPEN (Ka = 1016
M
1) (Equation 1), the binding
constant of Hsp33 for zinc (Equation 2) was calculated according to
Equation 3.
|
(Eq. 1)
|
|
(Eq. 2)
|
|
(Eq. 3)
|
where [Hsp33·Zn] corresponds to the amount of zinc released
from Hsp33 by the addition of PMPS; [Hsp33free] equals
[Hsp33total]
[Hsp33·Zn]; [TPENfree]
equals [TPENtotal]
[TPEN·Zn]; and [TPEN·Zn] corresponds to the amount of non-complexed Hsp33
[Hsp33free].
Similar experiments were performed with the Hsp33 mutant proteins;
however, PAR was used in the competition experiments instead of TPEN
(16). PAR has a lower affinity for zinc than TPEN does, allowing the
measurement of Hsp33 mutants that have a decreased affinity for zinc.
The Ka for Zn(PAR)2 complexes had been
calculated to be 2 × 1012
M
1 at pH 7.0, when the PAR
concentration is 100 µM and the zinc concentration is
below 12 µM (14, 16). Various concentrations of Hsp33
mutant proteins (2, 5, and 10 µM) were incubated in
metal-free 400 mM KCl, 40 mM HEPES-KOH, pH 7.0, and 100 µM PAR at room temperature. Equilibrium was
reached within the mixing time. The absorption at
A500 was determined. The calculated amount of
Zn(PAR)2 corresponded directly to the fraction of zinc-free
Hsp33 [Hsp33free]. The remaining zinc bound to Hsp33 was
released by the addition of 32 µM PMPS. This corresponded
to the fraction of zinc-complexed Hsp33 [Hsp33·Zn]. The apparent
zinc association constant of the Hsp33 mutant proteins was calculated
according to Equation 4.
|
(Eq. 4)
|
To extract zinc from Hsp33 wild type and the mutants by PAR, the
various reduced and zinc-reconstituted Hsp33 preparations (3 µM each) were incubated in 40 mM metal-free
HEPES-KOH, 400 mM KCl, pH 7.0, and increasing
concentrations of PAR. One minute after addition of PAR, the
A500 was determined to allow calculation of the
amount of Zn(PAR)2 complexes formed. Then, 20 µM PMPS was added to release all residual zinc from the
cysteine centers corresponding to the fraction of zinc-complexed Hsp33.
Absorption Spectra of Metal-free, Co(II)- and
Cd(II)-reconstituted Hsp33--
Metal-free Hsp33 (15 µM)
in 40 mM HEPES-KOH, pH 7.5, was supplemented with
increasing amounts of fresh CoCl2 or CdCl2, and the absorption spectra were immediately recorded using a Beckman spectrophotometer DU600. At the end of the titration, 30 µM ZnCl2 solution was added.
To analyze the number of thiolate anions present in wild type Hsp33 and
the mutants, the respective proteins (15 µM) were incubated in a 2-fold molar excess of fresh cadmium chloride, and the
absorption of the cadmium-thiolate charge transfer band was determined
at A250. This allowed the determination of the number of cysteines that coordinate the metal in the form of highly reactive thiolate anions. The extinction coefficient at 250 nm per
CysS-Cd bond is 5300 M
1
cm
1 (17).
Proteolytic Digests of Hsp33--
Zinc-reconstituted and
metal-free Hsp33 were prepared as described. To determine the
proteolytic sensitivity of both protein preparations, proteolytic
digests with trypsin and proteinase K were performed. 0.3 mg/ml Hsp33
was incubated in a final volume of 170 µl in the presence of 2 µg
of trypsin or 0.2 µg of proteinase K for 0, 2, 5, 7, and 10 min at
37 °C. After the respective incubation times, 30-µl aliquots were
taken, and the tryptic digest was terminated by the addition of 5 mM PMSF (in chloroform) and incubation on ice (2 min). The
samples were supplemented with non-reducing 5× Laemmli buffer and
boiled. The proteinase K digests were terminated by immediate boiling
of the samples for 5 min in the presence of Laemmli buffer. The samples
were loaded onto a 14% SDS-PAGE (NOVEX), and the protein bands were
visualized using a fast, highly sensitive Coomassie staining technique
(18).
Activity Measurements of Hsp33--
To analyze the chaperone
activity of Hsp33, the influence of Hsp33 on the aggregation of
refolding luciferase was tested (5). Firefly luciferase (Roche
Molecular Biochemicals) was denatured in a final concentration of 8 µM in 4.3 M Gdn·HCl for 2 h at room temperature. To initiate the refolding of luciferase, the unfolded enzyme was diluted 1:80 (final concentration 0.1 µM) into
1600 µl of 40 mM HEPES, pH 7.5, at 32 °C in the
absence or presence of Hsp33. Light scattering was monitored using a
Hitachi F4500 fluorimeter equipped with thermostated cell holder and
stirrer. Excitation and emission wavelengths were set to 350 nm, and
the excitation and emission slit widths were set to 2.5 nm.
To initiate the activation of Hsp33, reduced zinc-reconstituted or
metal-free Hsp33 (35 µM) was incubated in the presence of
2 mM H2O2 at 43 °C in the
absence or presence of freshly prepared CuCl2. Defined time
points after addition of H2O2, aliquots were taken and diluted 1:44 (0.8 µM final concentration) into
the refolding buffer, present in the cuvette. Then denatured luciferase
was added, and light scattering measurements were performed. To exclude reactivation by incubation at elevated temperature alone, activity of
Hsp33 was determined after incubation of Hsp33 ± CuCl2 in the absence of H2O2 for 5 min at 43 °C.
 |
RESULTS |
Hsp33 Coordinates Zinc via Its Four Universally Conserved
Cysteines--
Hsp33 is a recently identified chaperone whose activity
is redox-regulated (1). Under reducing conditions, Hsp33 is inactive. All six cysteines of Hsp33 are in the thiol state, and zinc has been
shown to be cysteine-coordinated (1). Upon activation of the chaperone
function of Hsp33 with oxidizing agents like H2O2, two intramolecular disulfide bonds form,
connecting the invariant cysteines Cys232 with
Cys234 and Cys265 with Cys268 (5).
This activation process of Hsp33 is paralleled by the release of zinc
(1). To analyze the zinc-binding properties of reduced Hsp33 in detail,
an assay was applied that allows the sequential determination of free
and cysteine-coordinated zinc within the same sample. This assay
exploits the unique properties of two reagents, PAR and PMPS (14). The
metal chelator PAR interacts with free zinc to form a
Zn(PAR)2 complex (Ka = 2 × 1012 M
1), which
strongly absorbs light at 500 nm. To detect zinc molecules that are
coordinated by high affinity cysteines, the mercurial agent PMPS is
added. PMPS forms mercaptide bonds with thiols, a process that can be
monitored by an increase in absorption at 250 nm. Within the mixing
time of the experiment, this thiol modification induces the release of
zinc into solution. Zinc is then rapidly chelated by PAR, producing an
intense red color. A PMPS titration experiment in the presence of PAR,
therefore, allows one to evaluate the number of cysteine residues
involved in the zinc coordination and to determine the total amount of
zinc bound to the protein.
To obtain a homogeneous preparation of reduced and metal-coordinated
protein, purified wild type Hsp33 (zinc content ~80%) was incubated
in DTT in the presence of additional zinc. Excess DTT and metal was
removed by PD10 gel filtration of the sample in metal-free HEPES-KOH
buffer. Incubation of 3 µM reduced Hsp33 in the presence
of 100 µM PAR resulted in a slight increase of A500, indicating that reduced Hsp33 had small
amounts of zinc associated via the surface (data not shown). The
remaining zinc could only be released by addition of PMPS indicating
that it is cysteine-associated (Fig.
1A). Stepwise addition of PMPS
led, after a short lag phase, to an increase in
A500 that was directly proportional to the
amount of PMPS added. In the linear range of the titration,
approximately four thiol groups had to be titrated with PMPS to induce
complete zinc release (Fig. 1A).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
Hsp33 coordinates zinc via its 4 conserved
cysteines. A, PMPS titration of reduced,
zinc-reconstituted wild type Hsp33. Hsp33 (3 µM) was
incubated in 40 mM metal-free HEPES-KOH, pH 7.5, in the
presence of 100 µM PAR. PMPS was titrated in 2.5 µM aliquots, and the absorption change at
A500 was monitored. The ratio of
Zn(PAR)2 complexes formed during the titration to molecules
Hsp33 was calculated. The ratio of molecules PMPS to molecules Hsp33
corresponds to the number of thiol groups that have to be titrated by
PMPS to induce zinc release. B, DTT treatment re-extracts
zinc from the Zn(PAR)2 complexes back into the Hsp33
apoprotein. After PMPS titration was complete (final concentration 20 µM PMPS) (A), 40 µM DTT was
added, and the decrease in A500 was monitored.
This decrease reflects the DTT-induced reduction of all
mecaptide-thiol bonds formed during the PMPS titration, and the
ability of reduced Hsp33 to reassociate zinc. C, thiol
titration and concomitant zinc release of Hsp33-C141D239S (Hsp33DS)
mutant protein. PMPS titration (1.5 µM per titration) of
zinc-reconstituted, reduced Hsp33-C141D/C239S (2.7 µM in 40 mM metal free HEPES-KOH, pH 7.5) was
performed in the presence of 100 µM PAR to monitor zinc
release (A500) or in the absence of PAR to
monitor the formation of mercaptide-thiol bonds
(A250).
|
|
We next tested if the PMPS-induced zinc release was reversible by
adding a 2-fold molar excess of DTT to the Hsp33/PMPS/PAR mixture
present at the titration end point. DTT should reduce all
mercaptide-thiol bonds formed during the PMPS titration in Hsp33 and
should allow the thiol groups in Hsp33 to re-extract zinc from the
Zn(PAR)2 complex. This should lead to a decrease in the
amount of Zn(PAR)2 complex and, therefore, to a decrease in
A500. As shown in Fig. 1B, after
addition of DTT, zinc that has been released from Hsp33 upon formation
of mercaptide-thiol adducts was indeed immediately re-coordinated by
the reduced thiols in apoHsp33. The total amount of zinc released
by PMPS and re-coordinated by apoHsp33 upon DTT treatment accounted to
one zinc atom per molecule Hsp33, establishing a 1:1
stoichiometry of zinc binding to Hsp33 (Fig. 1, A and
B).
Six cysteines exist in Hsp33. Four of these cysteines
(Cys232, Cys234, Cys265, and
Cys268) are invariant residues, present in all 31 organisms
from which Hsp33 has been sequenced. One cysteine, Cys141,
is moderately conserved and present in 11 of the 31 organisms. The
final cysteine, Cys239, is very poorly conserved and only
present in four Hsp33 homologues. All 6 cysteines in reduced Hsp33 were
able to form mercaptide-thiol bonds, as monitored by PMPS titrations
of Hsp33 in the absence of PAR (data not shown). PMPS/PAR titrations of
wild type Hsp33 revealed an initial lag phase, which is most likely due
to the PMPS titration of accessible cysteines that are not involved in zinc coordination (Fig. 1A). A mutant protein of Hsp33,
lacking the two less-conserved cysteines C141D and C239S, showed no
detectable lag phase during the PMPS titration, and zinc was completely
released by the addition of exactly 4 mol eq of PMPS (Fig.
1C). This implied that one of the less conserved cysteines,
which is highly accessible for PMPS modification and not involved in
zinc coordination, is responsible for the observed lag phase. The zinc
titration of the C141D/C239S mutant corresponded with the
titration of thiol groups in this protein (Fig. 1C). These
results strongly suggested that all 4 invariant cysteines are involved
in the high affinity zinc coordination of Hsp33.
To confirm that the
Cys-X-Cys-X27-32-Cys-X-X-Cys
motif of Hsp33 is required for zinc binding, cysteine mutants were constructed in which each of the 6 cysteines present in Hsp33 were
individually altered. In 5 of the 6 mutants constructed, the generally
conservative, but chemically inactive, serine substitution was chosen.
For Cys141, we chose to make an aspartic acid substitution,
because this residue was present in this position in nearly 50% of all
Hsp33 homologues. The relatively conserved nature of this position in the protein family suggested that this residue might play a role in
Hsp33 folding or stability. The mutant proteins were overexpressed in
the presence of 1 mM ZnCl2, purified to
homogeneity, and tested for their zinc-binding properties. As shown in
Table I, all cysteine mutants that had
one of the 4 conserved cysteines substituted for a serine residue
completely lacked detectable zinc in the purified protein preparation.
This strongly suggested that all 4 conserved cysteines are important
for zinc binding. In contrast, wild type Hsp33, the individual mutants
in the less conserved cysteines C141D and C239S as well as the double
mutant C141D/C239S showed between 75 and 90% zinc present in
the protein after purification. This showed that neither of the less
conserved cysteines is essential for zinc coordination.
View this table:
[in this window]
[in a new window]
|
Table I
Zinc content and thiol status of purified wild type Hsp33 and Hsp33
mutants
The number of cysteine residues present in the respective proteins is
shown in parentheses.
|
|
Although all proteins were purified in the absence of reducing agents,
wild type Hsp33, the C141D, C239S, and the C141D/C239S mutants
were predominantly in the reduced, zinc associated state. All other
mutant proteins showed very few accessible cysteines (Table I). Despite
the fact that these mutants lacked one of the conserved cysteines and
thus could not form both native disulfide bonds, less then one cysteine
was accessible in these mutants even when they were tested under
denaturating conditions (Table I). This suggested either the formation
of mixed disulfides with small molecules such as glutathione or the
presence of extra, non-native, disulfide bond(s) that involve the
non-conserved cysteines Cys141 or Cys239.
Preliminary analysis of the chaperone activities of these mutant proteins revealed significantly different chaperone activities, suggesting distinct roles for the individual cysteine/disulfide bonds
in chaperone function and redox regulation. A detailed analysis of the
respective cysteine mutants is underway which will allow us to dissect
further the functional roles of each of the individual conserved
cysteines in Hsp33.
After reduction and zinc treatment, all mutant proteins were capable of
approximately equimolar zinc binding (Table
II). The C239S mutant protein showed a
nearly identical PMPS titration as the wild type protein does, despite
the absence of one cysteine residue in the protein. This suggested that
the Cys239 residue is buried and titrated with PMPS only
after the zinc release, allowing this cysteine to go unnoticed in the
titration of the wild type protein. The C141D protein, on the other
hand, had no lag phase and contained 4 titratable cysteines despite the
presence of 5 cysteines in the protein. We interpret this as meaning
that in wild type Hsp33, Cys141 is the highly accessible,
reduced thiol group which reacts with PMPS prior to the titration of
the zinc-coordinating cysteines and that Cys141 is
responsible for the observed lag phase. All the mutant proteins that
lacked one of the conserved cysteines had the initial lag phase in the
PMPS titration, consistent with the interpretation that this lag is due
to the presence of Cys141 and needed approximately 3 additional mol eq of PMPS for complete zinc release. This agreed well
with the assumption that all four conserved cysteines of the
CXCX27-32CXXC motif are
involved in the zinc coordination of wild type Hsp33.
Binding Affinity of Zinc to Wild Type Hsp33 and the
Mutants--
Hsp33 mutants that lack any one of the 4 conserved
cysteines are unable to retain zinc throughout the purification process but are able to bind to zinc that has been added after reduction of the
purified protein. To analyze and compare the zinc affinity of wild type
Hsp33 and the mutant proteins, their zinc binding constants were
determined. To extract zinc from the wild type protein, the very high
affinity zinc chelator TPEN (Ka = 1016
M
1) needed to be used. Not even
millimolar concentrations of EDTA (Ka = 1014 M
1) were
sufficient to out-compete micromolar amounts of wild type Hsp33 for
zinc binding. This suggested that the zinc binding constant of Hsp33 is
higher than 1014 M
1.
Zinc-reconstituted Hsp33 was incubated in increasing concentrations of
TPEN and allowed to equilibrate for 16 h at 23 °C. Zinc-free and zinc-complexed TPEN were separated from Hsp33 by PD10 gel filtration, and the ratio of zinc-bound to zinc-free Hsp33 was determined using the PAR/PMPS assay (Fig.
2A). On the basis of Equation 3, the association constant for zinc binding of Hsp33 at 23 °C and
pH 7.5 was calculated to be 2.5 × 1017
M
1. This is similar to the zinc
binding constant determined for methionine synthase MetE
(Ka > 1017 at pH 7.0, 25 °C) (16)
and significantly higher than the zinc association constants reported
for the neural zinc finger factor NZF-1 (Ka = 1.4 × 1010 M
1
at pH 6.9, 25 °C) (19) or carbonic anhydrase (Ka = 0.8 × 1012 M
1
at pH 7.0, 30 °C) (20). Noteworthy, incubation of 40 µM wild type Hsp33 in 2 mM TPEN showed that
the apparent half-time of zinc release was only 160 ± 10 min at
23 °C. This fast dissociation rate of zinc indicated that TPEN
functions by "catalyzing" zinc release from Hsp33 rather than by
trapping zinc that has dissociated from Hsp33. Similar observations
have been made when the zinc release of carbonic anhydrase was studied
using dipicolinic acid (21) and explains the fast equilibrium
established between Hsp33 and TPEN in competition experiments.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 2.
Zinc binding constant of wild type Hsp33 and
Hsp33 single cysteine mutants. A, zinc binding constant
of wild type Hsp33. Wild type Hsp33 (40 µM) was incubated
in 40 mM metal-free HEPES-KOH in the absence or presence of
increasing concentrations of TPEN. After 16 h of incubation at
23 °C, aliquots were taken and purified with PD10 gel filtration.
The combined PMPS/PAR assay was applied to determine the amount of
residual zinc bound to wild type Hsp33. The Ka was
calculated to be 2.5 × 1017
M 1. B, zinc extraction
from Hsp33 wild type and mutants by PAR. Wild type Hsp33 and the mutant
Hsp33 proteins (3 µM each) were incubated in 40 mM metal-free HEPES-KOH, 400 mM KCl, pH 7.0, and increasing concentrations of PAR. 1 min after addition of PAR,
A500 was determined to calculate the amount of
Zn(PAR)2 complexes formed. Then 20 µM PMPS
was added to release all residual zinc from the cysteine centers to
determine the total amount of zinc bound. PAR was unable to release
significant amounts of zinc from ( ) wild type Hsp33 but induced the
zinc release from ( ) Hsp33 C232S, ( ) Hsp33 C234S, ( )
Hsp33 C265S, and from ( ) Hsp33 C268S.
|
|
To determine the zinc binding constant of the mutant proteins, a
different approach needed to be used since zinc dissociation experiments with TPEN indicated that the zinc binding constant of the
mutant proteins is several magnitudes lower than the binding constant
of the wild type protein (data not shown). Therefore, the metal
chelator PAR (Ka = 2 × 1012
M
1, at pH 7.0) was employed as a
competitor for zinc binding (16). Whereas PAR was unable to extract
zinc from the wild type protein, significant amounts of zinc were
released from the mutant proteins under the same assay conditions,
indicating that the mutants bound zinc less tightly (Fig.
2B). Equilibrium was reached within a few minutes of
incubation in PAR. This was similar to zinc binding measurements of the
MetE protein with PAR, where the equilibrium between PAR and the
protein was achieved within the mixing time of the experiment (16). To
determine the association constants for the mutant proteins, various
concentrations of the proteins (2-10 µM) were incubated
with 100 µM PAR at pH 7.0. The concentrations of
[Zn(PAR)2], [Hsp33·Zn], and [Hsp33free]
were determined using the PAR/PMPS assay (16). The binding constants
for zinc were calculated and found to be between 0.9 and 2.5 × 1014 M
1 at 23 °C,
pH 7.0, for all four mutants (Table III).
These experiments showed that although substitution of one of the four
cysteines did not abolish the ability of Hsp33 to coordinate zinc via
the remaining cysteines, it did result in a greater than 1000-fold decrease in the zinc binding constant. This shows that all 4 cysteines in the CXCX27-32CXXC
motif are important and about equally so in the zinc binding activity
of Hsp33.
Absorption Spectrum of Metal-reconstituted Hsp33--
Substitution
of Co2+ into the zinc-binding site of proteins provides a
useful method to evaluate the characteristics of the metal polyhedron
using spectroscopic techniques (22, 23). Metal-free Hsp33 was obtained
by incubating wild type Hsp33 in the presence of 2 mM TPEN
and 2 mM DTT for 4 h at 43 °C. The metal binding
affinity of Hsp33 was retained upon removal of zinc from the protein,
since addition of zinc to metal-free Hsp33 resulted in an immediate
reassociation of zinc into the apoprotein as monitored with the PAR
assay. Thiol titration with PMPS revealed that all 4 cysteines were
able to coordinate zinc in the reconstituted wild type protein.
Metal-free Hsp33 was incubated with increasing amounts of cobalt, and
the absorption spectra were monitored immediately after the cobalt
addition. As shown in Fig. 3,
A and B, two distinct new absorption bands
appeared that exhibited absorption maxima at 340 and 685 nm with
absorption shoulders at 620 and 710 nm. These absorption bands
increased in intensity until equimolar ratios of cobalt to Hsp33 were
titrated (Fig. 3, A and B). Higher concentrations
of cobalt did not change the absorption spectra of Hsp33. Subsequent
addition of zinc resulted in the immediate disappearance of these
absorption bands suggesting that zinc was capable of quickly displacing
cobalt from the cysteine center. This suggested an extremely fast
exchange reaction between the metals. The resulting absorption spectra
closely resembled the spectra of zinc-treated Hsp33 in the absence of
cobalt. The position of the 340 nm band in the absorption spectra of
cobalt-reconstituted Hsp33 is consistent with a ligand-metal charge
transfer band which indicates a charge transfer between Co(II) and
thiolate ligands (22, 24). The intensity of the absorption band at 340 nm was 3 600 M
1
cm
1. Given the calculated molar extinction
coefficients of the ligand-metal charge transfer band with 900-1300
M
1 cm
1
per Co(II)-CysS bond (25), it is likely that at least 3 and possibly
all 4 zinc-coordinating cysteines in Hsp33 are in the highly reactive
thiolate anion state. The intensities of the d-d ligand field
transition bands in the visible range of the spectrum (e.g.
685 = 780 M
1
cm
1) indicated a tetrahedral high spin cobalt
system (22).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 3.
Metal coordination induces thiolate anion
formation of the conserved cysteines of Hsp33. A and
B, cobalt reconstitution of Hsp33. Absorption spectra
(300-800 nm) of metal-free wild type Hsp33 (15 µM) in 40 mM HEPES-KOH, pH 7.5 (- - -) before and ( ) immediately
after addition of 20 µM freshly prepared
CoCl2. This was followed by the (···) addition of 30 µM ZnCl2, which immediately displaced cobalt
from the cysteine center as monitored by the decrease in absorbance.
The ligand-metal charge transfer band region is shown in A,
and the visible range of the spectrum is shown in B. C, cadmium reconstitution of Hsp33. Absorption spectrum of
metal-free wild type Hsp33 (15 µM) was recorded. Then,
freshly prepared CdCl2 (3 µM each) was
titrated, and the formation of the cadmium-thiolate (Cys-Cd) band at
250 nm was monitored (inset).
|
|
Similar results were obtained when cadmium was used to reconstitute
Hsp33. Hsp33 has an even higher affinity toward cadmium than toward
zinc, like model thiolate complexes and many other metalloproteins that
possess cysteine ligands (17). Hsp33 binds these metals with the
following order of affinity Co(II) < Zn(II) < Cd(II) (data
not shown). When cadmium was titrated, an immediate increase in the
cadmium thiolate charge transfer band at 250 nm was noticeable. Again,
equimolar amounts of cadmium to Hsp33 were necessary for the complete
titration (Fig. 3C, inset). The extinction coefficient of
cadmium-substituted Hsp33 at 250 nm was 21,500 M
1 cm
1
and revealed a value of 5300 M
1
cm
1 per Cd-CysS bond. This was very similar
to the molar extinction coefficient of Cd-CysS bonds reported for a
number of other cadmium-substituted metalloproteins (
250 = 5 300-5 500 M
1
cm
1) (17, 26) and confirmed that all 4 cysteines are in the thiolate anion state.
Similar extinction coefficients were obtained when zinc-reconstituted
Hsp33 was used, and cadmium was added subsequently. Within the mixing
time of the experiment, cadmium successfully competed with and replaced
zinc from this kinetically labile cysteine-containing metal site. The
molar extinction coefficient of the cadmium-reconstituted conserved
cysteine mutants was found to be lower by ~5500
M
1 cm
1.
This was very consistent with the presence of three thiolate anions
remaining in the mutant proteins, which are able to coordinate the
reconstituted metal.
Zinc Coordination Confers Major Protection of Hsp33 Against
Proteolytic Digestion--
Hsp33 coordinates zinc with high affinity.
Zinc-free and reduced Hsp33 migrates on native gels with a very
different mobility than zinc-containing and reduced Hsp33. This
mobility difference may be either due to the presence of additional
charges in the zinc-coordinated protein or due to major changes in the
conformation or to a combination thereof. To compare the conformation
of zinc-coordinated and metal-free Hsp33, proteolytic digests with
trypsin and proteinase K were performed. As shown in Fig.
4A, zinc coordination in Hsp33 confers a high resistance toward trypsin. Metal-free and reduced Hsp33
was degraded within the first 2 min of incubation in the presence of
trypsin. On the other hand, treatment of zinc-coordinated protein with
identical concentrations of trypsin did not cause significant
proteolytic digestion even after 10 min of incubation with trypsin at
37 °C. No stable tryptic fragments larger than 5-8 kDa were
observed when metal-free Hsp33 was digested. This suggests that zinc
binding strongly stabilizes Hsp33. Since the entire Hps33 molecule is
stabilized by zinc binding, the conformational changes triggered by
zinc dissociation appear to propagate outside of the zinc-coordinating
center, which is localized within the last 50 amino acids of the C
terminus of Hsp33. Zinc-containing Hsp33 also showed a high resistance
toward proteinase K digestion, whereas metal-free Hsp33 was immediately
degraded into numerous fragments (Fig. 4B). The proteolytic
pattern obtained with zinc-free Hsp33 was significantly different from
the fragment pattern obtained when metal-coordinated Hsp33 was digested
for an extended time. Our results show that zinc coordination
efficiently protects Hsp33 from proteolytic digestion.

View larger version (85K):
[in this window]
[in a new window]
|
Fig. 4.
Zinc coordination confers resistance toward
proteolytic degradation. A, tryptic digest of
metal-free (1st to 5th lanes) and
zinc-coordinated (6th to 10th lanes) wild type
Hsp33. For defined time points after addition of trypsin, aliquots were
taken, and the digest was terminated by the addition of 5 mM PMSF. B, proteinase K digest of metal-free
(1st to 5th lanes) and zinc-coordinated
(6th to 10th lanes) wild type Hsp33. For defined
time points after addition of proteinase K, aliquots were taken, and
the digest was terminated by immediate boiling of the samples in
Laemmli buffer.
|
|
Zinc Coordination Is Important for Activation Process of Hsp33 by
H2O2--
Hsp33 coordinates the redox-inactive
metal zinc with high affinity in the reduced state, and all 4 cysteines
appear to be in the highly reactive thiolate state. To analyze the
potential role of zinc in the activation process of Hsp33, activity
measurements were performed. Active and oxidized Hsp33 suppresses the
aggregation of chemically denatured luciferase in a
concentration-dependent manner (5). Reduced and
zinc-coordinating Hsp33 and reduced and metal-free Hsp33 were both
inactive. Even a 10-fold molar excess of either reduced protein
preparation was unable to influence the aggregation behavior of
refolding luciferase. Activation of reduced Hsp33 was induced by the
addition of H2O2 and incubation at elevated
temperatures. Within 60 min of incubation in
H2O2, significant reactivation occurred when
reduced Hsp33 was zinc-coordinated (Fig.
5B). Absence of zinc in Hsp33,
on the other hand, led to a very slow and incomplete reactivation,
indicating that the zinc coordination not only plays a major role in
stabilizing Hsp33 but is also directly involved in the activation
process of Hsp33 (Fig. 5A).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 5.
Zinc coordination is essential for fast and
successful reactivation of Hsp33 upon H2O2
treatment. A, reactivation of reduced metal-free
(black bars) or zinc-reconstituted (light gray
bars) wild type Hsp33 (35 µM) was initiated by the
addition of 2 mM H2O2 and
incubation at 43 °C. To determine the reactivation yields and rates,
Hsp33 aliquots were taken after the time points indicated and added to
the activity assay (final concentration 0.8 µM).
Chemically denatured luciferase was added (0.1 µM), and
the influence of Hsp33 on the light scattering of renaturating
luciferase was monitored. The light scattering signal reached after 6 min of incubation in the absence of molecular chaperones was set to 0%
activity. The light scattering signal reached after 6 min in the
presence of fully active Hsp33 was set to 100%. B,
reactivation of Hsp33 is accelerated by the presence of
CuCl2. H2O2-induced reactivation of
zinc reconstituted wild type Hsp33 (35 µM) was performed
as described in the absence (black bars) or in the presence
of 3.5 µM CuCl2 (light gray bars)
or 35 µM CuCl2 (dark gray bars).
Activity assays were performed as described in A. C, reactivation of metal-free Hsp33 in the presence of
stoichiometric amounts of CuCl2.
H2O2-induced reactivation of metal-free wild
type Hsp33 (35 µM) was performed as described in the
(black bars) absence or in the presence of (light gray
bars) 3.5 µM CuCl2 or (dark gray
bars) 35 µM CuCl2.
|
|
The reactivation process of Hsp33 was slower in these experiments
compared with earlier measurements where the ability of Hsp33 to
suppress the thermal aggregation of luciferase was analyzed (1). These
reactivation reactions were in part carried out in quartz cuvettes, UV
light, and at elevated temperatures, environmental conditions where
hydroxyl radicals are known to be produced. To analyze whether hydroxyl
radicals may indeed accelerate the activation process of Hsp33, Fenton
reagents (27) were added to the reactivation reaction. Unfortunately,
the "classical" hydroxyl radical-producing reagents Fe(II)
and Cu(I) but could not be used due to the fast oxidation of Fe(II) to
Fe(III) in HEPES buffer and due to interference of the Cu(I) solvent
with the chaperone assay. Therefore, the water-soluble Cu(II) was used
since it is known to become easily reduced to the hydroxyl
radical-producing Cu(I) in thiol-disulfide reactions (28, 29). As shown
in Fig. 5B, substoichiometric amounts of Cu(II) present in
the incubation reaction with H2O2 were
sufficient to significantly increase the reactivation rate of Hsp33.
They did so without changing the final activity of Hsp33. Within 5 min
of incubation in equimolar concentrations of Cu(II) and
H2O2, the reactivation reaction of Hsp33 was
75% complete. Cu(II) alone was unable to reactivate Hsp33 within the
time frame of the experiment, excluding the possibility of a direct
oxidation process of cysteines by copper. Moreover, metal competition
experiments revealed that copper is unable to replace zinc from the
zinc-binding site (data not shown). However, given the numerous
negatively charged amino acids that are present in Hsp33, nonspecific
copper association in the vicinity of the cysteines, cannot be
excluded. The significant acceleration of reactivation of Hsp33 in the
presence of copper suggested that hydroxyl radicals are indeed involved in the activation process of this chaperone.
Metal-free Hsp33 was also reactivated when equimolar amounts of copper
and H2O2 were present in the incubation
reaction, revealing that metal-free Hsp33 is still capable of
reactivation. The reactivation reaction was, however, reproducibly
slower than the reactivation reaction of zinc-associated Hsp33 and
required the presence of equimolar amounts of copper (Fig.
5C). In this case, we hypothesize that Cu(II) binds directly
to the cysteine center and, in cooperation with hydrogen peroxide,
induces the oxidation process and formation of the correct disulfide bonds.
 |
DISCUSSION |
Hsp33 is the first molecular chaperone whose activity is known to
be directly regulated by the redox conditions of the environment. Deletion mutants of Hsp33 are highly sensitive toward oxidative stress
treatment, suggesting that the chaperone action of Hsp33 plays a major
role in protecting cellular proteins against the deleterious effects of
reactive oxygen species (Ref. 1 and reviewed in Refs. 2 and 3). Under
normal conditions, the majority of cytosolic Hsp33 is reduced and
presumably inactive in the cell. Under oxidizing conditions, as is the
case during oxidative stress or heat treatment, two intramolecular
disulfide bonds are formed, and Hsp33 accumulates in the active,
oxidized state (1, 5). In the past few years, a growing number of pro-
and eukaryotic proteins have been identified that seem to be regulated
by similar means in response to changes in the redox potential of the
cytosol. Under oxidizing conditions, OxyR, a prokaryotic transcription
factor responsible for the transcription of antioxidant genes, forms an
intramolecular disulfide bond (30). This activation process is
accompanied by conformational changes that lead to the initiation of
gene transcription. On the other hand, RsrA, an anti-sigma factor in
Streptomyces coelicolor, is inactivated by disulfide bond
formation (31). In its oxidized state, RsrA is no longer capable of
interacting with the sigma factor R, which, in its non-complexed form,
induces the transcription of the thioredoxin system, an important redox
balancing system of the cytosol (31).
One factor that distinguishes Hsp33 from these other two
redox-regulated proteins is its high zinc binding affinity in the reduced, inactive state. We showed that Hsp33 coordinates one zinc atom
via its highly conserved
CXCX27-32CXXC motif in presumably tetrahedral geometry. This motif is clearly distinct from
all other zinc-binding motifs present in the Prosite data base
(Release 16, updated June 1, 2000), and we consider Hsp33 to
contain a previously undescribed zinc-binding motif (Table IV). Somewhat similar structural
zinc-binding motifs in which zinc is coordinated by two pairs of
cysteines in a tetrahedral geometry have been found in a number of
other metalloproteins including DksA/TraR C4-type zinc finger,
TFIIS zinc ribbon, and GATA-type zinc finger.
View this table:
[in this window]
[in a new window]
|
Table IV
Zinc-binding motifs
For simplicity, only those residues that have been directly implicated
as zinc ligands are shown, in all cases additional residues are
conserved.
|
|
The zinc binding affinity of reduced Hsp33 is very high (2.5 × 1017 M
1), and zinc
binding confers considerable stability to Hsp33 against proteolytic
digests as well as denaturating conditions. Not even incubation in 6 M Gdn·HCl permits the zinc-chelating agent PAR (Ka = 2 × 1012
M
1) to extract zinc from the wild
type protein (data not shown) indicating that at least the zinc-binding
domain in Hsp33 is an extremely stable folding unit. Oxidation of the
conserved cysteines to disulfide bonds, however, leads to the immediate
loss of zinc. This is accompanied by major conformational changes in
Hsp33 and activation of the chaperone function of Hsp33.
Zinc is a redox inert metal, and is often considered to play a purely
structural role when coordinated by 4 ligands. However, zinc-coordinating cysteine centers can serve as targets for reactive oxygen species such as H2O2, hydroxyl radicals,
and nitric oxide (NO) both in vitro and in vivo.
For instance, zinc levels increase dramatically in nucleus and
cytoplasm of eukaryotes upon NO stress, indicating that a number of
zinc-binding proteins lose their metal presumably due to the oxidation
of these cysteines (32). High affinity zinc-binding proteins such as
metallothionein (11) as well as certain zinc finger transcription
factors (33) have been shown to release their bound metal upon
oxidation. Oxidation of metal clusters in zinc finger proteins causes
the inactivation of the protein even when the zinc finger is not
directly involved in DNA recognition and binding (9). It appears,
however, that inactivation is reversible and does not lead to
irreversible unfolding or aggregation of the proteins. This suggests
that structural, zinc-coordinating cysteine centers are able to serve
an additional role by quickly sensing and responding to reactive oxygen
species, thereby leading to changes in protein conformation and
activity. To define whether an intact metal center is indeed needed for the oxidation process of Hsp33, metal-free Hsp33 was generated, and
reactivation experiments with H2O2 were
performed. It was shown that reactivation of metal-free Hsp33 was very
slow and incomplete. Several mechanisms could explain the role zinc
plays in enhancing the activation process of Hsp33. First, zinc
coordination may keep the reactive cysteines in a conformation that
allows the correct disulfide bonds to be formed. The extreme protease sensitivity of the metal-free, reduced Hsp33 is consistent with this
mechanism. Alternatively, zinc may play a direct or indirect role in
the catalytic mechanism of the activation process of Hsp33. Zinc is
capable of coordinating additional substrates such as H2O2 leading to structurally flexible systems
with five coordination sites (34). This may allow zinc to bring this
reactive oxidant into close proximity to the reactive cysteines of
Hsp33. Zinc may also alter the reactivity of the conserved cysteines by
reducing their pKa thereby keeping them in the
activatable thiolate anion state.
The question now arises, what distinguishes the highly reactive metal
center of Hsp33 from that of zinc finger proteins? The thiolate anions
of Hsp33 coordinate zinc with high affinity in presumably tetrahedral
coordination. This is very similar to zinc finger proteins. The
stability of zinc finger domains are equally high, and the spacing of
the cysteines are comparably close. Could the observed regulation of
Hsp33 by reactive oxygen species be not only similar to the subset of
redox-regulated zinc finger proteins studied so far but represent a
general mechanism of modulating zinc finger proteins? With the
development of in vivo thiol-trapping techniques (2), it
will soon be possible to monitor the in vivo thiol status of
cysteine-containing proteins under oxidative stress conditions like
aging and cancer (35, 36). This might contribute to our understanding
toward the severe changes observed in signal transduction pathways
during these pathological processes.
 |
ACKNOWLEDGEMENTS |
We are grateful for many helpful discussions
with Dr. Carol Fierke, Dr. Rowena Matthews, and Dr. Zhaohui Zhou. We
thank Arun Kumar and Alexandra Megner for their excellent technical assistance.
 |
FOOTNOTES |
*
This work was supported by a National Institutes of Health
grant (to J. C. A. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Biology,
University of Michigan, Ann Arbor, MI 48109-1048. Tel.: 1-734-764-8028; Fax: 1-734-647-0884; E-mail: ujakob@biology.lsa.umich.edu.
¶
Present address: School of Biosciences, Cardiff University,
Cardiff, CF 103US, UK.
PEW scholar.
Published, JBC Papers in Press, September 6, 2000, DOI 10.1074/jbc.M005957200
 |
ABBREVIATIONS |
The abbreviations used are:
DTT, dithiothreitol;
TPEN, N,N,N',N'-tetrakis(2-pyridyl-methyl)ethylenediamine;
PAR, 4-(2-pyridylazo) resorcinol;
PMPS, p-hydroxymercuri-phenylsulfonic
acid;
Gdn·HCl, guanidinium hydrochloride.
 |
REFERENCES |
| 1.
|
Jakob, U.,
Muse, W.,
Eser, M.,
and Bardwell, J. C. A.
(1999)
Cell
96,
341-352
|
| 2.
|
Aslund, F.,
and Beckwith, J.
(1999)
Cell
96,
751-753
|
| 3.
|
Ruddock, L. W.,
and Klappa, P.
(1999)
Curr. Biol.
9,
R400-R402
|
| 4.
|
Buchner, J.
(1996)
FASEB J.
10,
10-19
|
| 5.
|
Barbirz, S.,
Jakob, U.,
and Glocker, M.
(2000)
J. Biol. Chem.
275,
18759-18766
|
| 6.
|
Ruediger, S.,
Buchberger, A.,
and Bukau, B.
(1997)
Nat. Struct. Biol.
4,
342-349
|
| 7.
|
Richardson, A.,
Landry, S. J.,
and Georgopoulos, C.
(1998)
Trends Biochem. Sci.
23,
138-143
|
| 8.
|
Wu, X.,
Bishopric, N. H.,
Discher, D. J.,
Murphy, B. J.,
and Webster, K. A.
(1996)
Mol. Cell. Biol.
16,
1035-1046
|
| 9.
|
Park, J. S.,
Wang, M.,
Park, S. J.,
and Lee, S. H.
(1999)
J. Biol. Chem.
274,
29075-29080
|
| 10.
|
Swaroop, M.,
Bian, J.,
Aviram, M.,
Duan, H.,
Bisgaier, C. L.,
Loo, J. A.,
and Sun, Y.
(1999)
Free Radic. Biol. Med.
27,
193-202
|
| 11.
|
Maret, W.,
and Vallee, B. L.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
3478-3482
|
| 12.
|
Jacob, C.,
Maret, W.,
and Vallee, B. L.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
3489-3494
|
| 13.
|
Creighton, T. E.
(ed)
(1993)
Protein Structure: A Practical Approach
, pp. 155-167, IRL Press at Oxford University Press, Oxford
|
| 14.
|
Hunt, J. B.,
Neece, S. H.,
and Ginsburg, A.
(1985)
Anal. Biochem.
146,
150-157
|
| 15.
|
Anderegg, F.
(1967)
Helv. Chim. Acta
50,
2330-2332
|
| 16.
|
Zhou, Z. S.,
Peariso, K.,
Penner-Hahn, J. E.,
and Matthews, R. G.
(1999)
Biochemistry
38,
15915-15926
|
| 17.
|
Henehan, C. J.,
Pountney, D. L.,
Zerbe, O.,
and Vasak, M.
(1993)
Protein Sci.
2,
1756-1764
|
| 18.
|
Wong, C.,
Sridhara, S.,
Bardwell, J. C. A.,
and Jakob, U.
(2000)
BioTechniques
28,
426-432
|
| 19.
|
Berkovits, H. J.,
and Berg, J. M.
(1999)
Biochemistry
38,
16826-16830
|
| 20.
|
Hunt, J. A.,
and Fierke, C. A.
(1997)
J. Biol. Chem.
272,
20364-200372
|
| 21.
|
Hunt, J. B.,
Rhee, M.,
and Storm, C. B.
(1977)
Anal. Biochem.
64,
297-303
|
| 22.
|
Bertini, I.,
and Luchinat, C.
(1984)
Adv. Inorg. Biochem.
6,
71-111
|
| 23.
|
Maret, W.,
and Vallee, B. L.
(1993)
Methods Enzymol.
226,
52-71
|
| 24.
|
Huang, C.-C.,
Casey, P. J.,
and Fierke, C. A.
(1997)
J. Biol. Chem.
272,
20-23
|
| 25.
|
May, S. W.,
and Kuo, J.-Y.
(1978)
Biochemistry
17,
3333-3338
|
| 26.
|
Hasler, D. W.,
Faller, P.,
and Vasak, M.
(1998)
Biochemistry
37,
14966-14973
|
| 27.
|
Sutton, H. C.,
and Winterbourn, C. C.
(1989)
Free Radic. Biol. Med.
6,
53-60
|
| 28.
|
Chevion, M.
(1988)
Free Radic. Biol. Med.
5,
27-37
|
| 29.
|
Park, O. K.,
and Bauerle, R.
(1999)
J. Bacteriol.
181,
1636-1642
|
| 30.
|
Zheng, M.,
Aslund, F.,
and Storz, G.
(1998)
Science
279,
1718-1721
|
| 31.
|
Kang, J. G.,
Paget, M. S.,
Seok, Y. J.,
Hahn, M. Y.,
Bae, J. B.,
Hahn, J. S.,
Kleanthous, C.,
Buttner, M. J.,
and Roe, J. H
(1999)
EMBO J.
18,
4292-4298
|
| 32.
|
Berendji, D.,
Kolb-Bachofen, V.,
Meyer, K. L.,
Grapenthin, O.,
Weber, H.,
Wahn, V.,
and Kroncke, K. D.
(1997)
FEBS Lett.
405,
37-41
|
| 33.
|
Casadevall, M.,
and Sarkar, B.
(1998)
J. Inorg. Biochem.
71,
147-152
|
| 34.
|
Kaim, W.,
and Schwederski, B.
(1995)
in
Bioanorganische Chemie
(Elschenbroich, C.
, Hensel, F.
, and Hopf, H., eds)
, pp. 248-269, Teubner, Stuttgart
|
| 35.
|
Johnson, F. B.,
Sinclair, D. A.,
and Guarente, L.
(1999)
Cell
96,
291-302
|
| 36.
|
Stadtman, E. R.,
and Berlett, B. S.
(1997)
J. Biol. Chem.
272,
20313-20316
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us